The lab indicated that the recombinant protein of Indian mutant (B.1.617.2),
A.23.1(Unit Kingdom), AT.1 (Russia), B.1.1.7(Unit Kingdom), B.1.351 (South Africa),
B.1.616 (France), B.1.621 (Colombia), C.36 (Egypt), C.37 (Peru), P.1 (Japan/Brazil),
P.2 (Brazil) can be detected by Jinwofu SARS-CoV-2 Antigen Test Kit.
For the newly descovered mutant Omicron(B.1.1.529), we performed sequence
alignment analysis on its mutation sites, and found that all the mutation sites were
outside the epitope region recognized by the monoclonal antibody selected by our company.
By bioinformatics analysis, Jinwofu SARS-CoV-2 Antigen Test Kit can also effectively detect
mutant Omicron(B.1.1529)
CareStarfTM COVID-19 ANTIGEN RAPID TESTS
Why CareStartTM
COVID-19 Live infection 10 minutes Diagnostic Tests dose not require a machine reader! Abbott, Quidel, and BD require readers, that are in short supply.
â?¢ EASY TO USE
CareStart
â?¢ AVAILABILE Rapid Tests on the shelf available products (in inventory) with
We offer CareStartTM
reliable production and delivery schedules. Abbott, Quidel and BD testing cassettes are
in short supply with unreliable availability.
â?¢ FDA EUA
is currently the only Point-Of-Care rapid antigen test registered authorized under the FDA EUA.
CareStart
TM
CareStarfTM COVID-19 ANTIGEN RAPID TESTS Features
Identify individual's current infection status to COVID-19 Fast and easy to use in Point-of-Care setting
Qualitatively detect the SARS-CoV-2 nucleocapsid protein Use nasopharyngeal (NP) swab specimens
Reliable results only in 1O minutes
No special equipment or training required All-in-one package including collection swabs
High sensitivity (88.4�°/o) and specificity (100�°/o) Kit Components
20 test devices
20 extraction vials and caps
20 NP swabs
1 positive and 1 negative controls Package insert
Quick reference Instructions (QRI)
Product Description - SARS-CoV-2 Antigen Rapid Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet Covid-19 clinical criteria.
Product origin - Turkey / Istanbul
Key Specifications/Special Features - vitro diagnostic , Rapid Antigen Test Kit, SARS-CoV-2, Covid 19
SARS-CoV-2 Antigen Rapid Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet Covid-19 clinical criteria.
Key Specifications/Special Features - vitro diagnostic , Rapid Antigen Test Kit, SARS-CoV-2, Covid 19, Nasal Rapid Test Kit
Product Description - Covid-19 SARS-CoV-2 Saliva Antigen Rapid Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 Saliva antigen (Ag) in human oropharyngeal (OP), nasal (NS), nasopharygeal (NP) swab, saliva or gargled water specimens from individuals who meet Covid-19 clinical criteria.
Made in Canada
Health Canada approved
CE Mark and ISO certified
The product has proven to have 100% Specificity and 96% Sensitivety
Stock availabity: 2 Million tests/kit in Canada
Production: up to 5 Million tests/kit weekly
The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only.
PRODUCT INFORMATION:
Product: Rapid Respose
Sample: Nasal / Nasopharyngeal secretions
Format: Cassette
Quantity: 25 Tests/Kit per box
Time to result: 15 minutes
Storage Condition: 2-30 C/36-86 F
Test Principle: Immunochromatographic Assay
CONTENTS - Individually packed test devices
Extraction Buffer
Extraction tube
Nozzle with filter
Tube stand
Individually packed swabs
Package Insert
Contents:
Lancet, Pipette, Silica Gel, Alcohol Swab, Test cassette
Number of Kits in a Box:
15 tests
Storage Condition:
Room Temperature
Shipping Type:
Shipping storage condition Room temperature
Analysis Time:
15 Min <
In short:
In the IgG or IgM test line area, it reacts with locally bound anti-human IgG or IgM, respectively and forms a colored line. If sample does not contain any COVID-19 antibodies, a colored line showing a negative result will not appear in any of the Test Line Areas. As a positive check for the correct performance of the tape's procedure and operation, a colored line should always be appearing in the Control Line Area. If Control Line area is empty, then the test is invalid.
Contents:
Swab, Test Cassette, Specimen Tube, Medical Waste Bag,Silica Gel
Number of Test:
Disposable
Storage:
2C 30 C
Shipment Type:
2�°C â?? 30�°C
Analysis Time:
15 Minutes
Shortly:
This kit is a rapid chromatographic immunoassay for the
qualitative detection of SARS-CoV-2 Nucleocapsid Protein in nasal swab
as an aid in the scientific research of primary and secondary COVID- 19 infections.Packaging, package leaflet and manual customized for various markets.
mLab / m-screen Corona Antigen Test
Simple nasal swap* or nasopharyngeal swab** / Under 30 minutes / Sensitivity 98.32%** and 97.25%* / TCID50 115 / In stock in Germany / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / German Manufacturer / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Laihe / Novel Corona Antigen Test
Nasopharyngeal swab / under 30 minutes / Sensitivity 95.07% / CE marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute and IVD / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
1709 Rapid Test Kits Suppliers
Short on time? Let Rapid Test Kits sellers contact you.
